Eton Pharmaceuticals Inc (ETON)
3.75
+0.07
(+1.90%)
USD |
NASDAQ |
May 02, 16:00
3.71
-0.04
(-1.07%)
After-Hours: 20:00
Eton Pharmaceuticals Enterprise Value: 80.32M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 80.32M |
| May 01, 2024 | 78.52M |
| April 30, 2024 | 73.90M |
| April 29, 2024 | 74.41M |
| April 26, 2024 | 72.62M |
| April 25, 2024 | 64.14M |
| April 24, 2024 | 66.45M |
| April 23, 2024 | 68.25M |
| April 22, 2024 | 67.48M |
| April 19, 2024 | 65.94M |
| April 18, 2024 | 62.60M |
| April 17, 2024 | 64.65M |
| April 16, 2024 | 65.94M |
| April 15, 2024 | 66.71M |
| April 12, 2024 | 71.85M |
| April 11, 2024 | 72.36M |
| April 10, 2024 | 72.10M |
| April 09, 2024 | 75.70M |
| April 08, 2024 | 72.62M |
| April 05, 2024 | 76.21M |
| April 04, 2024 | 75.44M |
| April 03, 2024 | 76.47M |
| April 02, 2024 | 78.52M |
| April 01, 2024 | 80.32M |
| March 28, 2024 | 80.32M |
| Date | Value |
|---|---|
| March 27, 2024 | 81.61M |
| March 26, 2024 | 81.86M |
| March 25, 2024 | 83.66M |
| March 22, 2024 | 85.72M |
| March 21, 2024 | 76.98M |
| March 20, 2024 | 73.90M |
| March 19, 2024 | 74.93M |
| March 18, 2024 | 73.39M |
| March 15, 2024 | 82.89M |
| March 14, 2024 | 98.56M |
| March 13, 2024 | 99.07M |
| March 12, 2024 | 97.02M |
| March 11, 2024 | 101.13M |
| March 08, 2024 | 99.59M |
| March 07, 2024 | 99.33M |
| March 06, 2024 | 95.22M |
| March 05, 2024 | 96.51M |
| March 04, 2024 | 98.82M |
| March 01, 2024 | 98.56M |
| February 29, 2024 | 98.30M |
| February 28, 2024 | 99.07M |
| February 27, 2024 | 99.33M |
| February 26, 2024 | 98.82M |
| February 23, 2024 | 98.82M |
| February 22, 2024 | 98.82M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
40.92M
Minimum
Sep 26 2022
230.58M
Maximum
Feb 17 2021
104.26M
Average
95.89M
Median
Jul 23 2019
Enterprise Value Benchmarks
| Evoke Pharma Inc | 4.923M |
| Outlook Therapeutics Inc | 209.65M |
| NovaBay Pharmaceuticals Inc | 2.666M |
| Palatin Technologies Inc | 23.59M |
| iBio Inc | 16.94M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.256M |
| Revenue (Quarterly) | 7.313M |
| Total Expenses (Quarterly) | 9.306M |
| EPS Diluted (Quarterly) | -0.09 |
| Gross Profit Margin (Quarterly) | 49.64% |
| Profit Margin (Quarterly) | -30.85% |
| Earnings Yield | -0.80% |
| Normalized Earnings Yield | -0.80 |